FDA Requests Zantac Be Pulled From the Market

Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market.
Source: WebMD Health - Category: Consumer Health News Source Type: news